Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Post-Pandemic Possibilities: Writer Ramesh Ponnuru Offers Insight On What Comes Next

Host Joe Selvaggi talks with Bloomberg Opinion writer and National Review senior editor Ramesh Ponnuru about the national zeitgeist in a post-Covid, post-President Trump future.

Grading Education in a Pandemic: Survey Finds Teachers Pass, Administrations Fail & Students Incomplete

This week on Hubwonk, Joe Selvaggi discusses a recently released survey from Pioneer Institute and Emerson Polling, "Massachusetts Residents’ Perceptions of K-12 Education During the Covid-19 Pandemic," with Emerson's lead analyst, Isabel Holloway, and Pioneer Institute’s Charlie Chieppo.

Doctor Heal Thyself: Insider’s Prescription For Healthcare Reform

Host Joe Selvaggi talks with surgeon and New York Times bestselling author Dr. Marty Makary about the healthcare reform themes in The Price We Pay, the 2020 Business Book of the Year.  The discussion covers the value of price transparency, provider accountability, and performance information to drive better medical outcomes and improve doctor and patient satisfaction.

Travesty of Justice: Massachusetts Drug War Collapses on Lab Scandal

Joe Selvaggi talks with Pioneer Institute senior legal fellow Jim McKenna about Massachusetts’ drug prosecution cases resting on evidence produced by badly mismanaged drug testing labs, and the implications for potentially hundreds of thousands convicted on erroneous, tainted, or fabricated evidence.

Struggling For Sunshine: Transparency’s Power To Keep Leaders Accountable

/
Host Joe Selvaggi talks with Pioneer Institute's Mary Z. Connaughton about the value of transparency and Pioneer’s extensive work to provide greater access to legislative and policy information to hold elected officials accountable and build trust in our state government. Read Pioneer Institute's Sunshine Week Transparency Resolutions.

Traffic Strikes Back: New Transportation Strategies for Post-Pandemic Prosperity

Host Joe Selvaggi talks with Chris Dempsey, Director of Transportation for Massachusetts, about road and mass transit innovations that could address traffic challenges in a high-growth, post-pandemic economy.

Post-Pandemic Prospects: Tech Leaders’ Prescription for Preserving a Healthy Economy

/
Host Joe Selvaggi talks with Chris Anderson, President of the Massachusetts High Technology Council, about the reasons why Massachusetts has a thriving tech sector, what challenges his members have faced in the pandemic, and what he sees as the most prudent path toward future prosperity in the commonwealth.

Digesting Digital Medicine: Healthcare Benefits When Smart Pills Track When Taken

/
Host Joe Selvaggi and Pioneer Institute’s Bill Smith talk with Valerie Sullivan, President and CEO of EtectRX about the health care costs of improperly taking prescriptions and the promise of smart pills to signal and track medicines when ingested.

Patient-centered Model Outshines Insurance-centered Healthcare during Pandemic

/
Joe Selvaggi talks with Pioneer Institute Senior Fellow Josh Archambault about his newest research paper entitled, "Direct Health Care Agreements: A New Option For Patient-Centered Care That Costs Less and Reduces Provider Burn-out" and how this emerging service model provided its patients with comprehensive health service throughout the COVID-19 pandemic.

Wealth Migration Trends: Remote Work Technology Empowers Workers to Live Anywhere

/
Host Joe Selvaggi talks with Pioneer Institute’s Andrew Mikula about his recent research into migration trends of high-income individuals, how pandemic-related technologies may accelerate that movement, and what challenges these changes present for policy makers.